Suchergebnisse - %22COVID-19%22

PubPharm (802)

41

SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads

enthalten in: Bioorganic & medicinal chemistry letters | 2023

von Ghosh, A. | Shahabi, D. | Imhoff, M. | +6

42

Computational assessment of herbal medicine-derived compounds as potential inhibitors of SARS-CoV-2 main protease

enthalten in: Journal of biomolecular structure & dynamics | 2023

von Tao, Y. | Qu, H. | Wang, S. | +3

43

Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients : a randomized, double-blind, placebo-controlled clinical trial

enthalten in: Trials | 2023

von Hafizi, M. | Kalanaky, S. | Fakharzadeh, S. | +14

44

Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors

enthalten in: European journal of medicinal chemistry | 2023

von Tan, B. | Sacco, M. | Tan, H. | +5

45

Investigation of the interactions of HSA and SARS-CoV-2 papain-like protease against eugenol for novel COVID-19 drug discovery : spectroscopic and insilico study

enthalten in: Journal of biomolecular structure & dynamics | 2023

von Naz, F. | Khan, I. | Baammi, S. | +1

46

Local budesonide therapy in the management of persistent hyposmia in suspected non-severe COVID-19 patients : Results of a randomized controlled trial

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Hautefort, C. | Corré, A. | Poillon, G. | +13

47

The Relationship between COVID-19 Severity in Children and Immunoregulatory Gene Polymorphism

enthalten in: Viruses | 2023

von Kozak, K. | Pavlyshyn, H. | Kamyshnyi, O. | +3

48

Analyzing 3D structures of the SARS-CoV-2 main protease reveals structural features of ligand binding for COVID-19 drug discovery

enthalten in: Drug discovery today | 2023

von Xu, L. | Chen, R. | Liu, J. | +2

49

Inhibitors of SARS-CoV-2 main protease : Biological efficacy and toxicity aspects

enthalten in: Toxicology in vitro : an international journal published in association with BIBRA | 2023

von Viskupicova, J. | Rezbarikova, P. | Kovacikova, L. | +2

50

A 5-Lipoxygenase Inhibitor, Zileuton, Modulates Host Immune Responses and Improves Lung Function in a Model of Severe Acute Respiratory Syndrome (SARS) Induced by Betacoronavirus

enthalten in: Viruses | 2023

von Pereira, R. | Rabelo, R. | Oliveira, N. | +15